SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Celerum supports development for PlanSea Solutions

7 Jul 2020 07:00

RNS Number : 1824S
Frontier IP Group plc
07 July 2020
 

RNS Reach

AIM: FIPP

07 July 2020

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Portfolio news - Celerum to support software development for PlanSea Solutions Limited.

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Celerum Limited ("Celerum") has been sub-contracted to support software development for Aberdeen-based PlanSea Solutions Limited ("PlanSea").

Frontier IP holds a 33.8 per cent equity stake in Celerum.

The work builds on approaches proven in a number of projects undertaken by Celerum founder Professor John McCall, former Head of the School of Computing, Science and Digital Media at RGU.

Professor McCall has more than 25 years research experience in nature-inspired computing ("NIC"). NIC looks to develop new software and AI algorithms based on natural processes and behaviours. The technology also has the potential to tackle a host of other complex scientific, engineering and industrial challenges. They include applications developed for the transport and the telecommunications sector.

Other examples of NIC include particle swarm optimisation, based on how birds and fish behave in flocks and schools, and genetic algorithms, software techniques based on natural selection and evolutionary genetics.

PlanSea co-founder and CEO Jim Cargill said: "Innovation and new technology has a key part to play in the next chapter of our industry's future. We are looking forward to working with Celerum as one of our key service providers to deliver this important project for the sector."

 

 

Frontier IP Chief Executive Officer Neil Crabb said: "Industry engagement is a vital part of how we work with our portfolio companies, so we are delighted Celerum is involved in this important partnership with PlanSea."

ENQUIRIES

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive neil@frontierip.co.uk

neil@frontierip.co.uk

Andrew Johnson, Communications and Investor Relations

M: 07464 546 025

Group website: www.frontierip.co.uk

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

ABOUT PLANSEA SOLUTIONS LIMITED ("PSS")

 

PSS is a spin-out company from Robert Gordon University and holds the exclusive licence for the offshore vessel optimisation algorithms. PSS was established in 2017 specifically to focus on providing operational management control, fleet optimisation and vessel scheduling software for the offshore oil and gas marine support sector both in the UK and internationally.

 

For more information on PlanSea Solutions Limited visit www.plansea.co.uk or contact Jim Cargill jim@plansea.co.uk or on 07514088766

 

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKZGGNNVNGGZM
Date   Source Headline
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.